Inhibition of nitric oxide synthase prevents muscarinic and purinergic functional changes and development of cyclophosphamide-induced cystitis in the rat

Biomed Res Int. 2014:2014:359179. doi: 10.1155/2014/359179. Epub 2014 Jun 1.

Abstract

Nitric oxide (NO) has pivotal roles in cyclophosphamide- (CYP-) induced cystitis during which mucosal nitric oxide synthase (NOS) and muscarinic M5 receptor expressions are upregulated. In cystitis, urothelial muscarinic NO-linked effects hamper contractility. Therefore we wondered if a blockade of this axis also affects the induction of cystitis in the rat. Rats were pretreated with saline, the muscarinic receptor antagonist 4-DAMP (1 mg/kg ip), or the NOS inhibitor L-NAME (30 mg/kg ip) for five days. 60 h before the experiments the rats were treated with saline or CYP. Methacholine-, ATP-, and adenosine-evoked responses were smaller in preparations from CYP-treated rats than from saline-treated ones. Pretreatment with 4-DAMP did not change this relation, while pretreatment with L-NAME normalized the responses in the CYP-treated animals. The functional results were strengthened by the morphological observations; 4-DAMP pretreatment did not affect the parameters studied, namely, expression of muscarinic M5 receptors, P1A1 purinoceptors, mast cell distribution, or bladder wall enlargement. However, pretreatment with L-NAME attenuated the differences. Thus, the current study provides new insights into the complex mechanisms behind CYP-induced cystitis. The NO effects coupled to urothelial muscarinic receptors have a minor role in the development of cystitis. Inhibition of NOS may prevent the progression of cystitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / pharmacology
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Cyclophosphamide
  • Cystitis / drug therapy*
  • Cystitis / pathology
  • Cystitis / physiopathology*
  • Enzyme Inhibitors / pharmacology*
  • Enzyme Inhibitors / therapeutic use*
  • Immunohistochemistry
  • In Vitro Techniques
  • Male
  • Mast Cells / drug effects
  • Mast Cells / pathology
  • Methacholine Chloride / pharmacology
  • Muscle Contraction / drug effects
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Nitric Oxide Synthase / metabolism
  • Rats, Sprague-Dawley
  • Receptors, Muscarinic / metabolism*
  • Receptors, Purinergic / metabolism*
  • Urinary Bladder / drug effects
  • Urinary Bladder / pathology
  • Urinary Bladder / physiopathology

Substances

  • Enzyme Inhibitors
  • Receptors, Muscarinic
  • Receptors, Purinergic
  • Methacholine Chloride
  • Adenosine Triphosphate
  • Cyclophosphamide
  • Nitric Oxide Synthase
  • Adenosine